Canadian Government Issues Key Authorization for KSM’s

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
92
Canadian Government Issues Key Authorization for KSM’s Tailings Management Facility

TORONTO, June 27, 2017 (GLOBE NEWSWIRE) -- Seabridge Gold Inc. (TSX: SEA ) (NYSE: SA ) announced today that the Government of Canada has issued a regulatory amendment to Schedule 2 of the Metal Mining Effluent Regulations (MMER) under the Fisheries Act for Seabridge’s KSM Project located in northwestern British Columbia. The amendment authorizes certain natural water bodies frequented by fish for use in a Tailings Management Facility (TMF).

The regulatory amendment, which required a change in Canadian law, approves the construction of KSM’s TMF subject to strict bonding and fishery habit compensation requirements which were identified during the three year amendment review process. In the KSM Project design, the TMF is located in the upper tributaries of Teigen and Treaty Creeks which form part of the Nass River drainage. The TMF will store the Project’s ore-processing by-products in order to minimize environmental impacts downstream.

Seabridge Gold Chairman and CEO Rudi Fronk commented: “Receipt of this amendment represents a significant permitting milestone for KSM, equivalent in many ways to our receipt of environmental assessment approvals from the Provincial and Federal Governments in 2014. This approval further validates that KSM’s TMF is well-designed and environmentally responsible,” Fronk said.

“I am grateful to the Government of Canada for its support and I would like to express our appreciation and thanks to the Minister of Environment and Climate Change Canada and her technical team for reviewing and approving our regulatory amendment application. I would also like to acknowledge the Nis g a’a and the Tahltan Nations, the Gitanyow First Nation and other government regulators whose thoughtful input further strengthened our TMF design and ultimately contributed to the successful conclusion of this significant amendment review process.” 

Seabridge Gold holds a 100% interest in several North American gold resource projects. The Company’s principal assets are the KSM and Iskut properties located near Stewart, British Columbia, Canada and the Courageous Lake gold project located in Canada’s Northwest Territories. For a breakdown of Seabridge’s mineral reserves and resources by project and category please visit the Company’s website at http://www.seabridgegold.net/resources.php .

Neither the Toronto Stock Exchange, New York Stock Exchange, nor their Regulation Services Providers accepts responsibility for the adequacy or accuracy of this release.

All reserve and resource estimates reported by the Corporation were calculated in accordance with the Canadian National Instrument 43-101 and the Canadian Institute of Mining and Metallurgy Classification system. These standards differ significantly from the requirements of the U.S. Securities and Exchange Commission. Mineral resources which are not mineral reserves do not have demonstrated economic viability.

This news release includes certain forward-looking statements or information. All statements other than statements of historical fact included in this release, including, without limitation, statements regarding mineral reserves and resources of the Company and the potential economic benefits of the Project are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's plans or expectations include regulatory issues, market prices, availability of capital and financing, general economic, market or business conditions, timeliness of government or regulatory approvals and other risks detailed herein and from time to time in the filings made by the Company with securities regulators. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise except as otherwise required by applicable securities legislation.

ON BEHALF OF THE BOARD

"Rudi Fronk" Chairman & C.E.O.

For further information, please contact: Rudi P. Fronk, Chairman and C.E.O. Tel: (416) 367-9292 • Fax: (416) 367-2711 Email: info@seabridgegold.net

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZEISS Expands in China: Tackling Myopia's Surge

Updated Category News Views 157

ZEISS Sets Sights on China’s Myopia Epidemic They're calling myopia a public health crisis in China, and if you've seen the statistics, that's no exaggeration. Enter ZEISS Medical Technology, angling for a piece of the pie with their newly NMPA-approved PT LUNANA phakic intraocular lens. This is more than just another medical product, folks. It's a strategic entry into...

Continue Reading
Keenova Q3 2026: Net Sales Up, Losses Shrink

Updated Category News Views 29

A Strong Quarter Despite Some Knocks It ain't every day you see a company like Keenova Therapeutics clocking solid top-line growth, despite battling the waves of operational losses. Now, don't get me wrong; I ain't swooning over their near $96 million loss from continuing operations, but let me give credit where it's due—those sales numbers popped impressive. Pillars of...

Continue Reading
First Graphene Taps Deeper into US Defense Market

Updated Category News Views 109

Graphene Making Waves in Defense Fresh off the press, folks. First Graphene Limited is struttin' onto the US defense scene with a repeat order for its PureGRAPH®—a big deal in the realm of electrically conductive inks. The tally comes to around A$35,000 in an order from a longtime American customer. We're talking about inks that print circuits, sensors, and more,...

Continue Reading
Grandparents' Holiday Gift Picks: Expertly Tested Ideas

Updated Category News Views 21

Hunting for the Perfect Gift? Look No Further The holiday hustle and bustle inevitably sparks one of the annual dilemmas: What on earth should you buy those grandkids of yours? No need to get all twisted up this season. Enter ZestYears, the savvy go-to guide for grandparents who want to nail gift-giving without breaking a sweat or the bank. These folks, based out of...

Continue Reading
Kelley Blue Book Hits 100: Celebrating on Route 66

Updated Category News Views 36

If you've ever punched numbers on car values, you've probably bumped into Kelley Blue Book. This icon in vehicle valuation is marking its 100th birthday with a bang—road-tripping across Route 66 to sprinkle some joy across the dusty roads of history. Nostalgia Meets the Open Road The legendary Route 66 is not just the backdrop but the beating heart of this centennial...

Continue Reading
Tampa General Tackles Housing with The Linden Launch

Updated Category News Views 93

Building Bridges Between Work and Home Well, it’s about time someone threw in a lifeline to those drowning in Florida’s housing crisis. Tampa General Hospital, teaming up with The Michaels Organization, is setting the stage with 'The Linden': a solution pitched smack dab into the heart of affordability woes. This isn't your run-of-the-mill press release fluff. They've...

Continue Reading
Hexnode XDR Expands Threat Detection, MacOS Support

Updated Category News Views 24

Hexnode XDR: A Game Changer for MacOS Threats Ever heard of Hexnode? Well, today's chat is all about them beefing up their XDR platform. They’ve sagely added support for macOS—finally given the platform some love alongside Windows. It's about time! This move is a big win for everyone whose daily grind depends on keeping threats at bay across platforms. We’re talking...

Continue Reading
Caladan and NextBlock's Move Expands Crypto Liquidity

Updated Category News Views 55

Partnership to Expand Digital Asset Liquidity Looks like Caladan and NextBlock just threw their hats in the ring to shake up South Korea’s institutional digital asset market. These two big guns have cooked up a strategic collaboration, aiming to bring more global liquidity into the mix. Dive into what this means for the digital asset scene in South Korea. Why This Move...

Continue Reading
Giti Tire Hits Jaw-Dropping Speeds with Record-Breaker

Updated Category News Views 78

Blazing a New Trail in Automotive Excellence Who would've thought rubber on road could hit a jaw-dropping 503.17 km/h (312.65 mph)? Giti Tire just broke the mold, etching its name into the history books with the Guinness World Records™ title for their GitiSport e.GTR2 Pro tires. This isn't just about speed—it's about engineering marvel and pushing boundaries in...

Continue Reading
Blurry Vision Explained: Beyond Just a Lens Issue

Updated Category News Views 81

Why Your Vision Might Be Blurry: It's Not Always Simple Dr. Spencer Franz isn’t just another face behind an optometry chart. He’s tackling a topic as blurry as it is relatable—your vision. You'd think a simple tweak of your glasses script might do the trick, but surprise, surprise, vision issues are sneakier than that. Changes in prescriptions are a dime a dozen,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Cresco Labs: A Unique Investment Opportunity

Updated Category News Views 158

Assessing Cresco Labs: A Promising Investment Prospect With the cannabis market continuing to evolve, Cresco Labs Inc. stands out as an intriguing option for investors. Despite a backdrop of flat earnings and ongoing market challenges, analysts emphasize that Cresco (CRLBF) is holding the line as an "Overweight" stock. A recent analysis reveals Cresco's substantial...

Continue Reading
Context Therapeutics' First Quarter 2025 Results and Updates

Updated Category News Views 249

Context Therapeutics Releases First Quarter 2025 Financial Results Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company, made significant strides in Q1 2025, especially with its two product candidates, CTIM-76 and CT-95, currently in Phase 1 clinical trials. As of March 31, 2025, the company reported...

Continue Reading
Capricor's Challenges: FDA Review Delays and Legal Woes

Updated Category News Views 70

Capricor Under the Spotlight: FDA and SEC Concerns Ah, Capricor Therapeutics, Inc. (NASDAQ: CAPR)—a tale of high stakes and even higher expectations now hanging by a very taut thread. Investors are feeling the heat as the U.S. Food and Drug Administration (FDA) presses pause on Capricor's plans, and the courtroom drama unfolds with a securities class action looming over...

Continue Reading
Breaking New Ground: Wood Partners Launches Alta Flatirons

Updated Category News Views 258

Wood Partners Begins Construction on Alta Flatirons The 251-unit apartment community is one of the last remaining parcels of the Downtown Superior Masterplan. Overview of Alta Flatirons National multifamily developer Wood Partners has officially commenced the development of Alta Flatirons, a significant project located in a suburb near Boulder. This community, which will...

Continue Reading
Adobe Unveils New AI Tools to Maximize Content Engagement

Updated Category News Views 86

Adobe Unveils Exciting New AI-Driven Marketing Tools Adobe Systems Incorporated (NASDAQ: ADBE) has just rolled out a game-changing suite of updates to its Adobe Experience Cloud services. These innovations are designed to help brands enhance the performance of their AI-generated marketing content significantly. With a focus on advanced analytics and the ability to...

Continue Reading